Prevention and treatment of hepatitis B reactivation Updated recommendations for the prevention and management of hepatitis B virus reactivation (HBVr) for the growing number of patients on immunosuppressive drugs AGA published the first guideline on preventing and managing HBVr among individuals on immunosuppressive therapy in 2014
Hepatitis B Virus Reactivation AGA Guidelines The American Gastroenterological Association has issued an updated clinical practice guideline on prevention and management of hepatitis B virus reactivation in patients on immunosuppressive medication